Immunological Methods for the Detection and Determination of Connective Tissue Proteoglycans  by Caterson, Bruce et al.
0022-202X/82/790 1-0045s$02.00/0 
THE .JOURNAL OF INVESTIGATIVE DERMATOLOGY, 79:45s-50s, 1982 
Copyright © 1982 by The Williams & Wilkins Co. 
Vol. 79, Supplement I 
Printed in USA. 
Immunological Methods for the Detection and Determination of 
Connective Tissue Proteoglycans 
BRUCE CATERSON, PH,D, JOHN R. BAKER, PH,D, JAMES E. CHRISTNER, PH.D. AND 
JOHN R. COUCHMAN, PH.D. 
Institute of Dental Research, School of Medicine, and Diabetes Research and Training Center, University of Alabama, Birmingham, 
Alabama, US.A., and Unilever Research (JRC), Bedford, United Kingdom 
In this paper we report the use of immunological meth­
ods for specifically detecting and determining proteogly­
can in cartilage and other connective tissues. Antibodies 
(polyclonal and monoclonal) have been raised against 
specific components of cartilage proteoglycan aggre­
gates (i.e., proteoglycan monomer and link protein). Ra­
dioimmunoassay procedures and immunohistochemical 
procedures have been developed and used to demon­
strate the occurrence of cartilage-like proteoglycan and 
link protein in bovine aorta. Similarly, immunofluores­
cent studies have been used to analyze proteoglycan 
distribution in skin. Using antibodies specific for chon­
droitin-4-sulfated proteoglycan, their presence was dem­
onstrated in dermal connective tissue and connective 
tissue surrounding nerve and muscle sheaths. However, 
chondroitin-4-sulfated proteoglycan was completely ab­
sent in the epidermis of skin and areas surrounding 
invaginating hair follicles. These immunological proce­
dures are currently being used to complement conven­
tional biochemical analyses of proteoglycans found in 
different connective tissue matrices. 
Proteoglycans are ubiquitous components of all connective 
tissues. They are particularly abundant in those tissues which 
have greatest development of an extracellular matrix (e,g., 
cartilage, skin, artery walls, bone, and teeth). Cartilage proteo­
glycans have been the most thoroughly studied and they have 
served as a useful model for examining proteoglycan structure 
and function in other more complex connective tissue matrices. 
The major proteoglycans of cartilage, chondroitin sulfate pro­
teoglycans, associate to form large macromolecular aggregates 
with a molecular weight of 30-100 X 106 dalton, The aggregates 
consist of 3 classes of components (proteoglycan monomers, 
hyaluronic acid and the link proteins) which non-covalently 
associate with each other to form the macromolecular aggregate 
structures, A model for proteoglycan aggregate has been pro­
posed [1] and is illustrated in Fig 1. 
Proteoglycan monomers (�2,5 X 10" dalton) consist of a 
polypeptide core to which may polysaccharide chains (chondro­
itin sulfate and keratan sulfate) are covalently attached. A 
specific region of the protein core of the proteoglycan, and 
hyaluronic acid binding region, is responsible for the specific 
association with hyaluronic acid (HA). Stabilizing this interac­
tion are the link proteins [2,3], which may themselves specifi­
cally interact with both the hyaluronic acid and the proteogly­
can monomers. Beyond the hyaluronic acid binding region of 
the proteogiycan monomer, there is a polysaccharide attach-
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ment region which bears keratan sulfate (KS) and beyond that, 
the chondroitin sulfate (CS) attachment region, Several non­
covalent interactions are important in maintaining the proteo­
glycan aggregate structure. Interactions between the proteogly­
can monomers and HA (region 4, Fig 1) have been extensively 
studied [4-6]. Studies in the laboratory [7] have demonstrated 
the occurrence of an association of the link proteins with the 
proteoglycan monomers (region 5, Fig 1) and evidence for the 
association of the link proteins with HA (region 6, Fig 1) has 
also been reported [7,8]. These specific associations are ex­
tremely important in maintaining stable, functio:lal aggregate 
structures which in turn endow the tissue with its specific 
biomechanical and biophysical properties. 
Detailed analysis of proteoglycan structure by conventional 
biochemical procedures has been complicated by the inherent 
heterogeniety and polydispersity of the proteoglycan molecules, 
Immunological methods have offered the possibility of raising 
antibodies which specifically recognize the different antigenic 
determinants along the protein core of the proteoglycan and on 
the link proteins. Thus, immunological procedures can be used 
to detect and determine specific components of proteoglycan 
ag!:,rregates: proteoglycan monomer substructures (HA-binding 
region, CS-attachment region and KS-attachment region) and 
link protein, In this paper we report the development and use 
of immunological procedures to detect and determine proteo­
glycan components in cartilage and other connective tissues, 
These procedures are being used to complement conventional 
biochemical analyses of connective tissue proteoglycan distri­
bution and function. 
MATERIALS AND METHODS 
Materials and General Immunological Methods 
Chemicals, the preparation of antigens, immunization protocols and 
methods of immunological analyses have been described in our previous 
publications [9-12]. In brief, we have producep. polyclonal rabbit anti­
bodies (R#12) which specifically recognize link proteins from bovine 
nasal cartilage proteoglycan aggregates [9]. Radioimmunoassay proce­
dures have been developed which allow the detection and determina­
tion of nanogram amounts of link protein in various proteoglycan 
preparations [9,12]. Similarly, a polyclonal rabbit antibody preparation 
(R#19) has been prepared that specifically recognized chondroitinase 
ABC or chondroitinase AC II digested proteoglycan preparations [10l 
The specificity of this antiserum has been determined and indicates 
that the antibodies recognize delta-unsaturated glucuronic acid residues 
on chondroitin sulfate oligosaccharides with penultimate galactosa­
mine-4-sulfate residues [101. The antiserum possesses low titer anti­
bodies that recognize protein determinants on bovine proteoglycan 
preparations but these appear to not cross react with protein core 
determinants of other species. 
Recently, we have produced several monoclonal antibody prepara­
tions which recognize specific determinants on proteoglycan monomers 
and link protein [11]. The methods used for immunization, fusion 
(hybridization), cloning and determinations of antibody specificity are 
given in reference 1 L 
Determination of Link Protein in Bovine Nasal Cartilage, Aorta 
and Corneal Tissue Samples 
Bovine nasal cartilage, bovine aorta and bovine cornea samples were 
obtained fresh (within 15 mins of slaughter) from the local slaughter 
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FIG 1. Schematic model of cartilage proteoglycan substructures. 
The cartoon emphasizes several interaction sites (region 1-7) that are 
important in maintaining the integrity of the proteoglycan aggregate 
structure. CS-chondroitin sulfate, KS-keratan sulfate, HA-hyalu­
ronic acid. The symbols y and cj> denote N- and O-linked oligosaccha­
rides, respectively. (Note this figure has been reproduced from reference 
1 1.) 
house (Polar Lockers, Bessemer, AL) and frozen on Dry Ice for trans­
portation to the laboratory. All the tissue samples were obtained from 
the same animaL The tissues were freed of adherent loose connective 
tissue, diced into small pieces, frozen in liquid nitrogen and milled on 
a Wiley Mill cooled with liquid nitrogen. In a pilot experiment, samples 
of milled bovine nasal cartilage were extracted by conventional proce­
dures (8 hr at 4°C, 4 M guanidine HCI containing protease inhibitors) 
or with 5% SDS heated at 100° C for 20 min and then extracted a 
further 8 hr at 25°C. The purpose of these experiments was to see if 
link proteins could be quantitatively extracted from tissues in hot SDS. 
The results of this pilot study are shown in Table I and are discussed 
in the "Results and Discussion" section. 
In a separate experiment, milled tissue samples, 0.33 g cornea, 0.52 
g cartilage and 0.5 g aorta, were suspended in 2, 2.5, and 2.5 ml of 5% 
SDS in PBS-azide (5% SDS in 0.15 M NaCl, 0.03% NaN" 0.01 M sodium 
phosphate, pH 7.4), respectively. Tissues were extracted by heating the 
samples for 30 min at 100°C, cooling them to room temperature and 
stirring the tissue suspensions a further 60 min. The extract suspensions 
were cooled at 40 C, in order to precipitate excess SDS, centrifuged 
at 1,000 g for 10 min at 4°C and the supernatant collected and assayed 
for the presence of link protein using radioimmunoassay procedures 
[9,12]. Previous studies had indicated that heating at 100°C in the 
presence of SDS caused an approximate 33% loss of antigenicity of 
standard link protein preparations. In order to compensate for this loss 
of antigenicity, a standard link protein preparation was treated the 
same as the bovine tissue samples. Competitive binding radioimmu­
noassay procedures were used to determine the link protein present in 
the standard heated and unheated link protein preparations. The 
relative loss of antigenicity of the link standards upon heating was 
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TABLE I. Differential extractibility of proteoglycan and link protein 
from milled bovine nasal cartilage. 
Extraction Protein Uronic Gal N Acid conditions'l A2f!o (filllol GluN 
e/ml) (ratio) 
A. 4M GuHCI'; 4°C; 1.92 11.09 12.1 
8 hr 20 min 
B. 4M GuHCI'; 4°C; 2.01 11.08 13. 9 
8 hr at 20 min at 
100°C; 
C. 4M GuHCI'; 20 min at 1.55 7.52 14.6 
100°C; 8 hr at 4°C 
D. 5% SDS; 20 min at 2.43 N.D. 8.2 
100°C; 8 hr at 25°C 
a 1 gm milled cartilage extracted in 10 mL 
h Corrected for loss of antigenicity upon heating. 
'Contained protease inhibitors Oegema et al (1975). 
N.D.-not determined. 
Link Link 
Pro- Pro-
tein teinh 
(fl!(/ml) 
66.2 97.3 
56. 0 82.1 
34.4 51.3 
62.4 93.1 
subsequently used to correct for the absolute amount of link protein 
present in the SDS extracts of the bovine tissue samples. 
Immunohistochemical Studies 
In general, the methods of immunohistochemical analyses of rat ear 
tissue samples were as has been described by Couchman et al [13]. 
Fresh rat ear samples were collected, frozen and thin sections (5-10 
/Lm) obtained for immunofluorescent analyses. Tissue sections were 
treated with either chondroitinase ABC (Miles Laboratories) or testic­
ular hyaluronidase (Worthington) prior to exposure to antibody. Con­
trol tissue sections (no enzyme treatment and/or no antibody treat­
ment) were included in the analyses. Antiserum dilutions were made in 
0.1 % bovine serum albumin in PBS-azide. A VII" dilution of R#19 
antiserum was used. FITC-conjugated Goat-anti-rabbit immunoglobu­
lin (,/"IK)) was used as the fluorescent labeled second antibody. This 
second antibody preparation had been pre-absorbed with an acetone 
powder of normal rat skin prior to its use in the immunofluorescent 
studies described below. 
RESULTS AND DISCUSSION 
Quantitation of Link Protein in Bovine Cartilage, Aorta and 
Corneal Samples 
It has been suggested that the occurrence of the link proteins 
in cartilage is unique to the proteoglycan aggregates that occur 
in that connective tissue [14]. However, recent studies in this 
laboratory [15] and others [16] have indicated that cartilage­
type proteoglycans and link protein occur in aorta. In the past, 
the inability of researchers to isolate intact proteoglycan aggre­
gate structures from connective tissues other than cartilage has 
probably been due to endogenous degradation of the macro­
molecular aggregates during extraction and isolation. Immu­
nological procedures (Ouchterlony immunodiffusion) were used 
to qualitatively identify link protein in bovine aorta [15]. How­
ever, there has been a need for methods of isolating and 
quantitating link protein in more complex connective tissue 
matrices other than cartilage. 
In this laboratory we have developed radioimmunoassay 
procedures for quantitating link protein in cartilage proteogly­
can preparations [9]. These procedures allow the quantitation 
of antigens that contain 'denaturing' agents such as SDS and 4 
M guanidine hydrochloride. The results shown in Table I indi­
cate that the link proteins from bovine nasal cartilage can be 
rapidly and quantitatively extracted in solutions containing 5% 
SDS that has been heated to 100°C for 20 min. The results of 
comparing radioimmunoassay analyses of 4 M guanidine and 5% 
SDS extracts of powdered bovine nasal cartilage samples are 
shown in Table I. The SDS extract of powdered bovine nasal 
cartilage has a higher protein content (A2Ho) than the conven­
tional 4M guanidine extract. Hexosamine analyses of the ex­
tracts (Table I) indicate that the SDS extract is relatively 
enriched in tissue glycoproteins or keratan sulfate proteogly­
cans as evidence by the increased glucosamine content of the 
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extract. These results indicate that 5% SDS is a suitable solvent 
for quantitatively extracting link proteins from cartilage. In this 
procedure, heating the sample at 100nC markedly reduces the 
risk of endogenous proteolysis during extraction. The single 
step procedure of extraction of cartilage link protein using hot 
SDS has provided a rapid method for detecting similar antigens 
in other more complex connective tissues. 
In a separate experiment, powdered tissue samples from 
bovine cartilage, cornea and aorta were extracted in 5% SDS 
heated at 100° C for 20 min, and the presence of the link proteins 
determined by competitive binding radioimmunoassay proce­
dures (Fig 2a). Analyses of the competitive binding curves that 
were generated by several dilutions of the bovine tissue extract 
supernatants indicate that the link proteins are present in both 
the cartilage and aorta tissue extracts but little or no inhibition 
is observed with the components of the corneal extract super­
natant indicating the absence of link proteins in corneal tissue 
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FIG 2. a, Competitive binding radioimmunoassay for the determi­
nation of link protein in hot 5% SDS extracts of milled bovine aorta, 
cornea, and nasal cartilage. Results are expressed as the percent inhi­
bition of serial dilutions of aliquots from the SDS supernatants of each 
of the extracts. b, Radioimmunoassay inhibition curves of a standard 
bovine link protein preparation that was either untreated or heated in 
SDS for 30 min at lOO°C. The relative decrease in the inhibition of the 
heated link protein preparation (37O/C) was used to correct for the 
absolute amount of link protein present in each of the tissue extracts . 
and suggesting the absence of link protein stabilized proteogly­
can aggregate structures. 
Quantitation of the amount of link protein present in the 
extracts was achieved by comparing the competitive binding 
curves (Fig 2a) to those generated by untreated and heat­
treated bovine link protein standards (Fig 2b). Calculations 
from this analysis indicated that bovine nasal cartilage and 
bovine aorta contain 4.375 mg and 0.085 mg, respectively, of 
link protein/gm wet powdered tissue. Immunofluorescent stud­
ies of bovine aorta (results not shown) indicate that link-stabi­
lized proteoglycan aggregates occur predominantly in the media 
of the aorta in regions surrounding smooth muscle cells. This in 
part accounts for the lesser link protein content of aorta com­
pared to nasal cartilage, i.e., a large part of the aorta mass 
comes from adventitia smooth muscle cells. 
Immunofluorescent Studies on Rat Ear Tissue 
Analyses of the specificity of our rabbit #19 (R#19) antise­
rum has indicated that it contains antibodies which specifically 
recognize oligosaccharides of chondroitin-4-sulfate that contain 
terminal delta-unsaturated hexuronic acid residues adjacent to 
galactosamine-4-sulfate [10]. This particular antigenic deter­
minant is generated from the digestion of chondroitin-4-sulfate 
with either chondroitinase ABC or chondroitinase AC II. Chon­
droitinase ABC digestion of derma tan sulfate also generates the 
same characteristic nonreducing terminal disaccharide. 
Chondroitinase ABC digestion of cartilage proteoglycans 
from several different species (bovine, human, monkey, sheep, 
chicken, and rat) generates the antigenic determinants recog­
nized by R#19 antiserum, the relative antigenicity of these 
chondroitinase-treated proteoglycan preparations being depen­
dent upon the chondroitin-4-sulfate content of the original 
proteoglycans (results not shown). Thus there is the potential 
of using this antiserum on connective tissues containing chon­
droitin-4-sulfated or derma tan sulfate proteoglycans that have 
been treated with chondroitinase ABC and then detecting the 
distribution of these proteoglycan species using immunohisto­
chemical localization procedures. An example of the use of this 
type of procedure is given below. 
Rat ear was chosen because it contains several distinct ana­
tomical regions which may contain chondroitin sulfate or der­
matan sulfate proteoglycans. Tissue sections were treated with 
chondroitinase ABC or testicular hyaluronidase (which de­
grades chondroitin sulfate but does not generate the antigenic 
determinant recognized by R#19 antiserum) prior to reaction 
with R#19 antiserum. The distribution of R#19 antigen/anti­
body complexes was shown after reaction with a fluorescent 
labeled (FITC) Goat-anti-rabbit globulin second antibody. The 
results of these immunohistochemical analyses are shown in 
Fig 3. 
With chondroitinase ABC pretreatment, cartilage (Fig 3a) 
and connective tissue around muscle and nerve fiber bundles 
stain brightly (Fig 3b). Dermal connective tissue stains brightly, 
however, epidermis of skin and hair follicles are completely 
negative (Fig 3c). Hyaluronidase pretreatment shows some 
"nonspecific" staining of cartilage (Fig 3d). Similar nonspecific 
staining was observed in sections that had had no enzyme 
treatment but to a lesser extent suggesting the presence of some 
low titer cross reating antibodies in the R#19 antiserum. No 
connective tissue staining was seen in connective tissue sur­
rounding muscle or in the dermis after hyaluronidase treatment 
(Fig 3e and 3fj. 
Thus, these experiments illustrate the use of rabbit #19 
antiserum in the localization of chondroitin sulfate or derma tan 
sulfate proteoglycan in several different connective tissue mat­
rices (skin, muscle, and cartilage). The potential use of differ­
ential digestion of tissues with chondroitinase ABC and chon­
droitinase AC II to immunochemically distinguish the location 
of chondroitin sulfate and derma tan sulfate proteoglycans in 
the extracellular matrix is currently under investigation. 
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FIG a. Immunohistochemical localization of proteoglycans in rat ear connective tissues. a,d, Cartilage; b,e, muscle ; c,f, skin. Sections a,b and 
c had been pretreated with chondroitinase ABC and sections d,e and {with testicular hyaluronidase proir to their reaction with ]{#19 antiserum 
and FITC -labeled Goat-anti-rabbit second antibody. 
Munoclonal Antibody Studies 
The introduction of monoclonal antibody techniques de­
scribed by Kohler and Milstein [17] has offered the potential 
for identifying individual antigenic polypeptide or polysaccha­
ride substructures in connective tissue proteoglycans. In recent 
studies in this laboratory we have been able to generate several 
mouse hybridoma lines which synthesize monoclonal antibodies 
specific for different types of antigenic determinants on bovine, 
human and rat cartilage proteoglycans. The specificities of 
some of these hybridoma clones are summarized in Table II. 
All of the clones show a broad range of specificities toward a 
vareity of proteoglycan core preparations from different species 
and from various proteoglycan substructures. Currently our 
best characterized monoclonal antibody is that of 1/20/5-D-4. 
the specificity of which will be described in a separate com­
munication [18]. In brief, detailed immunochemical analysis 
has indicated that the mouse immunoglobulin (IgGl) produced 
by the hybrid om a specifically recognizes structural determi­
nants associated with the keratan sulfate binding region of 
cartilage proteoglycans (Fig 1, region 2). The antigenic deter­
minant recognized by this monoclonal immunoglobulin is pres­
ent on cartilage proteoglycans from a wide variety of species 
(human, bovine, sheep, monkey, chicken and shark cartilage 
sources). Furthermore, the 1/20/5-D-4 antibody recognizes 
both skeletal and corneal keratan sulfate preparations suggest­
ing that the antigenic determinant is a structural feature shared 
by both polysaccharide moieties and not the polypeptide back­
bone, as skeletal and corneal keratan sulfate have different 
amino acid sequences at the site of polysaccharide attachment 
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TABLE II. Specificity of monoclonal antibodies raised against chondroitinase ABC digested proteoglycan monomer preparations 
Clone Antigen HAC BNC-Proteoglycan RC Antibody (ABC)- (ABC)- (ABC)-identification injected CORE CORE AID! cs-o KS-P HABR CORE HABR subclass 
1/20/5-D-4 HAC(ABC) -CORE + + + + + Gl 
4/08/I-B-4-Br. BNC (ABC) -CORE + + + + + GI 
2-B-4-F7 + N.D. + + + (-) Gl 
9-A-2-Ar. + (+) (+) + Gl 
5/06/I-B-5-CIO RC(ABC)-CORE N.D. + + Gl 
3-B-3-CJ + + (+) + + M 
4-B-6 (+) (+) (+) + M 
ABBREVIATIONS: HAC-human articular cartilage; BNC-bovine nasal cartilage; RC-rat chondrosarcoma; (ABC)-CORE-chondroitinase 
ABC digested proteoglycan; A1Dl-proteoglycan monomer fraction; CS-O-chondroitin sulfate oligosaccharides; KS-P-keratan sulfate peptides; 
HABR-hyaluronic acid binding region; and N.D.-not determined. + = positive, (+) = weak positive, - = no reaction. 
to the protein core of the proteoglycan [19]. In contrast to the 
specificity of several of the other monoclonal hybrids outlined 
in Table II, the 1/20/5-D-4 immunoglobulin recognizes native 
proteoglycan monomer (BNC-AIDl, Table II) without prior 
chondroitinase or hyaluronidase treatment as a means of ex­
posing the antigenic determinants on the proteoglycan. 
The specificity of the 4/0B/I-B-4-B6 monoclone is similar to 
that of the 1/20/5-D-4 hybridoma (Table II). The detailed 
specificity of the other monoclonal hybrids shown in Table II 
are currently under investigation in our laboratory. The 5/06/ 
4-B-6 mono clone recognizes antigenic determinants which are 
most common to the hyaluronic acid binding region (HABR) of 
rat chondrosarcoma proteoglycan. A similar but distinctly dif­
ferent range of specificity is observed with 4/08/2-B-4-F7• Re­
cent studies have indicated that this antibody specifically rec­
ognizes oligosaccharides of chondroitin-4-sulfate containing 
delta unsaturated hexuronic acid residues i.e., it has a specificity 
similar to the polyclonal R#19. Further characterization of the 
specificity of these clones may provide a useful means of isolat­
ing and thus characterizing peptides from the Hl�BR (Fig 1, 
regions 3,4 and 5) of proteoglycan monomers. The overall aim 
of our monoclonal antibody studies is to generate a set of well­
characterized monoclonal antibody preparations that can be 
used in both quantitation and immunohistochemical localiza­
tion of specific proteoglycan components in various connective 
tissue matrices. 
GENERAL DISCUSSION 
Immunological procedures provide an extremely useful, spe­
cific means of complementing conventional biochemical analy­
ses of complex tissue macromolecules. The inherent heterogen­
iety and polydispersity of connective tissue proteoglycans make 
them a prime candidate for using immunological procedures as 
a tool in unravelling the complexities of their structure. Poly­
clonal antibody procedures [9,20,21] have already been used to 
show that the link proteins and proteoglycan are structurally 
distinct components of proteoglycan aggregates. Immunological 
procedures have been used to demonstrate in aorta the presence 
of "cartilage-like" proteoglycans with a hyaluronic acid binding 
region and link proteins [15] . In this paper we have reported 
the use of SDS extraction procedures for detecting and deter­
mining the link proteins in milled tissue samples. These proce­
dures can be applied to analyses of other connective tissues in 
studies examining whether the link proteins and thus link 
protein stabilized proteoglycan aggregate structures occur in 
those tissues. 
The characterization of polyclonal antibodies that recognize 
carbohydrate determinants (chondroitin-4-sulfate) of proteo­
glycan molecules [10] has provided a useful tool for immuno­
histochemical localization of similar structures in a wide variety 
of tissue (skin, muscle and cartilage). The same antiserum 
(R#19) has been used by Hedman et al [22] to identify and 
localize chondroitin sulfate proteoglycans in the pericellular 
matrix of human skin fibroblast cultures. These studies have 
indicated that the chondroitin-sulfate proteoglycans partly co-
distributes with heparan sulfate proteoglycan, fibronectin and 
collagen at the sites of cellular adhesion. 
The recent introduction of monoclonal antibody technology 
into the field of biochemistry offers the greatest potential for 
detection, determination and localization of specific proteogly­
can moieties in connective tissues. A monoclonal antibody that 
recognizes oligosaccharides containing saturated chondroitin-6-
sulfate residues, which result from testicular hyaluronidase 
digestion of proteoglycans, has just been recently reported by 
Jenkins, Hall, and Dorfman [23]. Thus, the possibility arises of 
generating a range of monoclonal antibodies that specifically 
recognize antigenic carbohydrate determinant on proteoglycans 
after glycosidase digestion of the polysaccharide chains. Indeed, 
the use of the polyclonal (R#19) antiserum and the monoclonal 
1/20/5-D-4 immunoglobulin reported in this paper coupled 
with a monoclonal antibody such as that reported by Jenkins, 
Hall, and Dorfman [23] would provide a powerful tool for the 
immunohistochemical and biochemical analyses of chondroitin-
4-sulfated, chondroitin-6-sulfated and keratan sulfate substi­
tuted proteoglycans in various connective tissues. 
Monoclonal antibodies have been used to specifically locate 
proteoglycan core polypeptides synthesized in vitro in cell-free 
biosynthesis studies [24]. Currently, in this laboratory, we are 
using monoclonal antibodies to isolate and characterize specific 
peptide sequences of the polypeptide core of the proteoglycan 
monomer and the link proteins with an overall aim of obtaining 
a better understanding of the structure and function of proteo­
glycans in extracellular matrix. 
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